These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8638366)
1. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer. Egawa S; Satoh T; Iwamura M; Aihara M; Kuwao S; Uchida T; Koshiba K Urology; 1996 Apr; 47(4):548-52. PubMed ID: 8638366 [TBL] [Abstract][Full Text] [Related]
2. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report. Greene DR; Taylor SR; Wheeler TM; Scardino PT Cancer Res; 1991 Aug; 51(15):4084-9. PubMed ID: 1855223 [TBL] [Abstract][Full Text] [Related]
3. Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate. Lerner SE; Jacobsen SJ; Lilja H; Bergstralh EJ; Ransom J; Klee GG; Piironen T; Blute ML; Lieber MM; Zincke H; Pettersson K; Peterson D; Oesterling JE Urology; 1996 Aug; 48(2):240-8. PubMed ID: 8753736 [TBL] [Abstract][Full Text] [Related]
4. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer. Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840 [TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701 [TBL] [Abstract][Full Text] [Related]
6. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age. Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055 [TBL] [Abstract][Full Text] [Related]
8. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. Greene DR; Rogers E; Wessels EC; Wheeler TM; Taylor SR; Santucci RA; Thompson TC; Scardino PT J Urol; 1994 May; 151(5):1301-7. PubMed ID: 8158775 [TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468 [TBL] [Abstract][Full Text] [Related]
10. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242 [TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. Lerner SE; Blute ML; Bergstralh EJ; Bostwick DG; Eickholt JT; Zincke H J Urol; 1996 Jul; 156(1):137-43. PubMed ID: 8648775 [TBL] [Abstract][Full Text] [Related]
12. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
13. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384 [TBL] [Abstract][Full Text] [Related]
14. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Ward JF; Bartsch G; Sebo TJ; Pinggera GM; Blute ML; Zincke H Urol Oncol; 2004; 22(1):40-7. PubMed ID: 14969803 [TBL] [Abstract][Full Text] [Related]
15. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry. So MJ; Cheville JC; Katzmann JA; Riehle DL; Lohse CM; Pankratz VS; Sebo TJ Mod Pathol; 2001 Sep; 14(9):906-12. PubMed ID: 11557788 [TBL] [Abstract][Full Text] [Related]
16. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [TBL] [Abstract][Full Text] [Related]
17. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer. Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920 [TBL] [Abstract][Full Text] [Related]
18. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239 [TBL] [Abstract][Full Text] [Related]
19. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
20. Predicting pathological stage of localized prostate cancer using volume weighted mean nuclear volume. Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Takeuchi H J Urol; 2000 Nov; 164(5):1587-90. PubMed ID: 11025710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]